Organon, a global woman’s health company, recently announced its launch of two biosimilar products in Canada.
On November 7, Organon announced the launch and availability of AYBINTIO in Canada....more
On May 19, 2022, Viatris Inc. and Biocon Biologics Ltd. announced that ABEVMY, a bevacizumab biosimilar, is now available in Canada. According to the press release, Viatris and Biocon Biologics co-developed ABEVMY, which...more